We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$110B
AUM Growth
+$10.8B
Cap. Flow
+$4.52B
Cap. Flow %
4.11%
Top 10 Hldgs %
23.63%
Holding
4,320
New
332
Increased
2,194
Reduced
1,423
Closed
241

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$290M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$259M
3
JNJ icon
Johnson & Johnson
JNJ
+$245M
4
JPM icon
JPMorgan Chase
JPM
+$133M
5
MSFT icon
Microsoft
MSFT
+$111M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$175M
2
KSU
Kansas City Southern
KSU
+$105M
3
XLI icon
State Street Industrial Select Sector SPDR ETF
XLI
+$97M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$50.8M
5
BDX icon
Becton Dickinson
BDX
+$42.3M

Sector Composition

Rank Sector Weight
1 Technology 14.49%
2 Financials 8.91%
3 Healthcare 8.14%
4 Industrials 6.57%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UEIC icon
2651
Universal Electronics
UEIC
$66.6M
$909K ﹤0.01%
18,735
– –
UFCS icon
2652
United Fire Group
UFCS
$1.38B
$908K ﹤0.01%
32,747
– –
OCUL icon
2653
Ocular Therapeutix
OCUL
$2.22B
$907K ﹤0.01%
63,933
+4,279
+7% +$65K
PSP icon
2654
Invesco Global Listed Private Equity ETF
PSP
$253M
$907K ﹤0.01%
11,845
+2,605
+28% +$203K
BVS icon
2655
Bioventus
BVS
$1.17B
$905K ﹤0.01%
+51,432
New +$829K
IGE icon
2656
iShares North American Natural Resources ETF
IGE
$781M
$905K ﹤0.01%
29,741
+1,568
+6% +$46.8K
WSBC icon
2657
WesBanco
WSBC
$4.1B
$905K ﹤0.01%
25,394
+1,364
+6% +$51.1K
SPDW icon
2658
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
$903K ﹤0.01%
24,535
+534
+2% +$19.8K
RARE icon
2659
Ultragenyx Pharmaceutical
RARE
$2.6B
$900K ﹤0.01%
9,441
-6,277
-40% -$654K
MLP icon
2660
Maui Land & Pineapple Co
MLP
$310M
$895K ﹤0.01%
83,375
+7,000
+9% +$76.7K
RRC icon
2661
Range Resources
RRC
$9.33B
$895K ﹤0.01%
53,423
-223,083
-81% -$2.8M
GLO
2662
Clough Global Opportunities Fund
GLO
$257M
$894K ﹤0.01%
73,851
+1,205
+2% +$15.1K
CLAR icon
2663
Clarus
CLAR
$145M
$893K ﹤0.01%
+34,747
New +$741K
AM icon
2664
Antero Midstream
AM
$10.5B
$891K ﹤0.01%
85,748
-4,891
-5% -$46.7K
VSEC icon
2665
VSE Corp
VSEC
$6.48B
$891K ﹤0.01%
17,994
+1,729
+11% +$79.4K
MATX icon
2666
Matsons
MATX
$6.39B
$890K ﹤0.01%
13,913
+7,286
+110% +$476K
BF.A icon
2667
Brown-Forman Class A
BF.A
$13.1B
$889K ﹤0.01%
12,608
+1
+0% +$71
IHIT
2668
DELISTED
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
$889K ﹤0.01%
91,219
+14,203
+18% +$135K
DB icon
2669
Deutsche Bank
DB
$72.1B
$888K ﹤0.01%
67,859
+4,136
+6% +$56.1K
PROF
2670
Profound Medical
PROF
$242M
$888K ﹤0.01%
54,560
+19,054
+54% +$354K
RIGS icon
2671
ALPS Strategic Income Fund
RIGS
$60.6M
$887K ﹤0.01%
35,724
+12,199
+52% +$302K
LHCG
2672
DELISTED
LHC Group LLC
LHCG
$887K ﹤0.01%
4,431
+1,407
+47% +$282K
AMRX icon
2673
Amneal Pharmaceuticals
AMRX
$6.02B
$886K ﹤0.01%
173,052
+3,000
+2% +$17.1K
CVS icon
2674
CALL
CVS Health
CVS
$121B
$886K ﹤0.01%
73,300
-23,700
-24% -$1.94M
GTO icon
2675
Invesco Total Return Bond ETF
GTO
$2.48B
$886K ﹤0.01%
15,527
+4,849
+45% +$275K
105 106
107
108 109

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Raymond James & Associates held 4,320 positions worth $110B, up 11% from $99.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.52B of net new capital in Q2 2021, opening 332 new positions and adding to 2,194 existing holdings. Its largest new stake was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $175M trimmed.

  • Raymond James & Associates's largest Q2 2021 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $290M increase.
  • Raymond James & Associates's biggest Q2 2021 reduction was Amgen, cutting an estimated $175M.
  • Raymond James & Associates fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $19.1M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $110B portfolio in Q2 2021.
  • Raymond James & Associates opened 332 new positions and closed 241 in Q2 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.